Allegheny Health Network

Paul B. Renz, DO, discussed the ideal uses of MR-LINAC in pancreatic, prostate, liver, head and neck, and rectal cancers.

Ariel Lopez-Chavez, MD, discusses the role of comprehensive genomic profiling in small cell lung cancer management.

AHN is leading cancer care through innovative radiation techniques and technologies to shorten treatments and limit side effects for patients in western PA, including Erie.

AHN is first in the region to offer pioneering HIFU treatment for prostate cancer.

AHN’s new LDRT program provides a non-invasive treatment option for joint pain.

In January, AHN welcomed Chirag Shah, MD, as chair of its Department of Radiation Oncology.

Alan H. Bryce, MD, discusses areas of need to help guide treatment decisions in the clinic for prostate cancer management.

Paul B. Renz, DO, discusses anecdotal changes observed by clinician researchers using the MR-LINAC system.

Paul B. Renz, DO, discusses the ideal uses of magnetic resonance-guided linear accelerator system.

The Allegheny Health Network Cancer Institute announced the launch of its comprehensive Community Cancer Patient Ambassador Program.

Cyrus M. Khan, MD, discusses how treatment paradigms for chronic lymphocytic leukemia have changed in recent years, particularly regarding frontline therapy options.

Ariel Lopez-Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

Allegheny Health Network is proud to offer a comprehensive program dedicated to providing the highest quality care for patients with esophageal and gastric cancer.

Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.

Ariel Lopez-Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have progressed after first-line chemotherapy.

Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the availability of CAR T-cell therapy.

In an interview with Targeted Oncology, Ariel Lopez-Chavez, MD, discussed recent developments in the small cell lung cancer space.

Ariel Lopez-Chavez, MD, discusses the efficacy of immunotherapy for the potential treatment of extensive-stage small cell lung cancers.

Ariel Lopez-Chavez, MD, provides an overview of the most promising advancements in targeted therapies for the treatment of small cell lung cancer.

Cyrus M. Khan, MD, highlights some of the most recent and significant advancements in chronic lymphocytic leukemia treatment.

Clinicians at the AHN Cancer Institute lead the way with CAR T-cell therapy and other innovative treatments for hematological cancers.

AHN Cancer Institute’s Centers of Excellence unite teams of experts to provide patients with high-quality, collaborative care in a supportive environment.

The cancer navigation program at Allegheny Health Network supports all cancer patients from diagnosis to treatment and beyond.

The fight against pancreatic cancer is a complex one, marked by challenging outcomes and a constant search for effective treatments. But at the Allegheny Health Network Cancer Institute, a team of specialists are turning the tide on the disease through early intervention, collaboration, and research.

As part of its Speaking Out series, Patrick Wagner, MD, discusses eligibility and considerations for oncolytic viral therapies.

As part of its Speaking Out video series, Howard D. Edington, MD, explores how oncolytic viruses are revolutionizing personalized cancer therapy, the challenges of interpreting vast genetic data, and the exciting potential of these targeted therapies.

Targeted Oncology spoke with Howard D. Edington, MD, about how experts are addressing the potential of resistance challenges with oncolytic viruses as part of its Speaking Out video series.

Targeted Oncology spoke with Howard D. Edington, MD, about the advancements in engineering oncolytic viruses to be able to target specific cancers and various combination therapies with the novel treatment.

Immune therapy drugs show promise in treating esophageal cancer.

Ariel Lopez-Chavez, MD, emphasizes the critical need for improved second-line therapies in small cell lung cancer.